- The Mariners are one of only a few teams open to adding payroll in deadline trades, which one official describes as not “as good as having prospects, but it is an asset.” The M’s began 2017 with a record payroll of more than $155.2MM, so with such a major financial investment already made, it makes sense that GM Jerry Dipoto and company are willing to spend a bit more to get the team over the hump. Dipoto recently stated that the team is still planning to add at the deadline, though Seattle ends the first half with a 43-47 record (albeit four games out of a wild card spot).
[SOURCE LINK]
Mariners Rumors
Dipoto: Mariners Don't Anticipate Selling
- Mariners GM Jerry Dipoto suggests that he still doesn’t perceive a need to shake things up too drastically at the deadline, despite a lull that has the M’s now sitting four games under .500. As MLB.com’s Greg Johns reports, Dipoto says that the team’s “roster plan has never really changed.” While buy and sell-side opportunities could arise at the deadline, it seems a major shift in either direction is unlikely. Starting pitching, clearly, is a prime need. “We’re not going to empty both barrels to try to go out and find the ace to perch atop the rotation to take us to the promised land, because that guy doesn’t exist,” said Dipoto. But he also noted that the trade deadline is but one of “two windows when you can access starting pitching” and promised at least to “stay in tune with” the market for starters.
Hisashi Iwakuma Receives Shoulder Injections After Setback
Mariners righty Hisashi Iwakuma is not progressing as had been hoped, as Ryan Divish of the Seattle Times reports. Following another setback, he has received cortisone and platelet-rich plasma injections in his troublesome right shoulder.
The hope, of course, is that this course of treatment will spur healing and finally allow Iwakuma to maintain steady progress. But the expectation had been that the veteran starter would long since have advanced back to the majors.
Seattle’s rotation is in better shape now than it has been at times, with Felix Hernandez and James Paxton returning and rookie Andrew Moore showing well in his first two MLB starts. Ariel Miranda and Sam Gaviglio are producing solid results, though their peripherals portend some regression.
Still, Iwakuma’s halting recovery is an ongoing concern for a club that continues to hover around .500 — along with much of the rest of the American League. Indeed, Divish notes that there’s at least a strand of thinking in the organization of the belief that Iwakuma won’t contribute again this season.
It’s still anyone’s guess just how the M’s will approach the deadline with the division out of reach but a Wild Card berth still fully plausible. Seattle will have an opportunity to see how Iwakuma progresses over the next three weeks or so, and the on-field results will also impact the calculus. If the team looks into additions, though, the rotation arguably represents the primary area of need — particularly with southpaw Drew Smyly now ruled out for the year following Tommy John surgery.
Mariners Release Nick Hagadone
- In another minor swap, the Giants purchased Tyler Herb from the Mariners for an undisclosed sum, both teams announced. He’ll actually represent the player to be named later in the deal that sent Chris Heston to Seattle, Henry Schulman of the San Francisco Chronicle tweets, with some undisclosed technicality requiring the particular treatment. The 25-year-old was taken in the 29th round of the 2014 draft. He made it up to the Double-A level last year and has thrown well there upon a repeat assignment. Herb has made it through 98 innings in 16 starts on the year, posting a 3.31 ERA with 8.1 K/9 against 2.8 BB/9.
- The Mariners released southpaw Nick Hagadone, according to Triple-A Tacoma announcer Mike Curto (via Twitter). As Curto notes, Hagadone has been particularly impressive of late. The 31-year-old has seen action in parts of four MLB seasons, all with the Indians, but missed all of last year after an elbow fracture. He landed in Seattle on a minors deal and has thrown 33 1/3 innings of 3.51 ERA ball — with 9.5 K/9 against 3.5 BB/9 — since arriving in Tacoma. (It could well be, then, that Hagadone utilized an opt-out clause, though we’ve heard no indication of that as of yet.)
AL International Signings: 7/2/17
Here are some notable American League international signings not yet covered elsewhere on MLB Trade Rumors. All signing information can be found in these invaluable compilations of the initial flurry of July 2 action from Baseball America’s Ben Badler and MLB.com’s Jesse Sanchez; the information here is from those sources unless otherwise credited…
- The Yankees have agreed to sign Venezuelan outfielder Everson Pereira and shortstop Roberto Chirinos. Pereira will receive a $1.5MM bonus, while Chirinos gets $900K. The Yankees are also seen as the favorites to sign Dominican shortstop Ronny Rojas, with Sanchez projecting a $1.05MM bonus. Badler tweets that Rojas isn’t eligible to officially sign until August, when he turns 16 years old.
- The Blue Jays have reached agreement with Brazilian right-hander Eric Pardinho on a $1.4MM bonus, as well as signing Dominican shortstop Miguel Hiraldo to a $750K deal.
- The Tigers agreed to sign Venezuelan shortstop Alvaro Gonzalez for a $1MM bonus.
- The Indians have reached deals with Venezuelan shortstop Aaron Bracho ($1.5MM) and Dominican outfielder George Valera ($1.3MM according to Sanchez, $1.2MM according to Badler).
- The Angels signed Bahamanian outfielder Trent Deveaux, with Jeff Fletcher of the Orange County Register reporting that Deveaux will receive a $1.2MM bonus.
- The Mariners have a $1.75MM agreement with Dominican outfielder Julio Rodriguez, as well as a $1.225MM agreement with Venezuelan shortstop Juan Querecuto.
- The Rangers agreed to nine-figure deals with a trio of prospects. Venezuelan outfielder Wilderd Patino will receive a $1.3MM bonus, while Venezuelan shortstop Keyber Rodriguez and Mexican right-hander Damian Mendoza each get bonuses worth $1MM.
Mariners Outright Pat Light
The Mariners have outrighted right-handed pitcher Pat Light, per a club announcement. That opens a 40-man roster spot, though it’s not immediately clear whether the team has plans for how to use it.
Seattle claimed the 26-year-old Light off waivers from the Pirates just under two weeks ago, though his stay on the 40-man was brief. Light has gone from the Red Sox to the Twins (in exchange for Fernando Abad) to the Pirates (for cash) to the Mariners all in a span of roughly 11 months.
It’s not hard to see the appeal of Light, who runs his fastball up to the upper 90s and averages nearly 95 mph on the pitch. He’s had no trouble missing bats in the minors and turned in a tantalizing 2.37 ERA with 9.9 K/9 against 4.5 BB/9 in 38 Triple-A frames last season. However, control problems have plagued the hard-throwing Light throughout his career (63 walks in 99 Triple-A innings), and he’s posted particularly unremarkable numbers in Triple-A this season. Through 28 innings between the Triple-A affiliates for the Pirates and Mariners, Light has a 4.82 ERA with a greatly diminished 6.4 K/9 rate and a still-problematic 5.8 BB/9 rate.
Drew Smyly To Undergo Tommy John Surgery
The Mariners have announced that lefty Drew Smyly will undergo Tommy John surgery for a torn ulnar collateral ligament. He is expected to miss the standard twelve to fifteen months in recovery.
That’s obviously devastating news for the 28-year-old southpaw, who had been hoping to work back from elbow issues that have put him on the shelf all year. He had shown quite well in the World Baseball Classic, with enhanced velocity, leading to hopes for a big first season in Seattle.
Instead, it now seems possible that Smyly won’t ever make an appearance for the M’s, who traded Mallex Smith and others to acquire his rights over the winter. Smith had been added earlier that day in a clearly related swap that sent pitching prospect Luiz Gohara to the Braves.
Smyly is earning $6.85MM this year and would command the same through arbitration in 2018 — his final trip through the process. It’s still possible that Seattle could attempt to work out some kind of arrangement to keep him in the organization for the future, but it obviously makes little sense for the team to pay him a significant salary for a year that will be spent rehabbing.
Last year was a rough one for the southpaw, who scuffled to a 4.88 ERA over 175 1/3 innings, though it also represented his first thirty-start campaign in the big leagues. He also still managed a healthy 8.6 K/9 against 2.5 B/9, with 32 home runs and a below-average 67.7% strand rate contributing to the ugly results.
Given his age, Smyly still has a shot at returning for many more years of pitching. Of course, he’ll need not only to work back from the UCL replacement, but also to find a way to avoid future elbow problems. (He had been among the highest-risk players identified by MLBTR contributor Bradley Woodrum in a 2016 study, and the risks for another will only increase.)
For the Mariners, the news confirms what the club surely already feared: there won’t be a reinforcement coming to the team in 2017. With Felix Hernandez and Hisashi Iwakuma showing their age, and James Paxton coming back down to earth of late, there are questions at the front of the staff.
There are depth concerns, too. While Sam Gaviglio owns a 3.38 ERA through 45 1/3 innings, the metrics don’t like his chances to maintain that performance. Similarly, Ariel Miranda has been solid but is benefiting from a likely-unsustainable .226 BABIP. It’s anyone’s guess what the team can hope to receive from Andrew Moore and others.
The fact that there’s a potential need doesn’t mean that the M’s can afford to go out and add a top-line starter, of course. Several quality arms could be available, of course, but there’ll be competition and steep asking prices. While Seattle has positioned itself as a win-now organization, it’s also a notable consideration that the AL West seems out of reach, meaning any present-focused moves come with the likely upside of earning a Wild Card berth.
Pitching Injury Notes: Smyly, Weigel, Keuchel, Nats, Salazar, Hendricks, Finnegan
The Mariners got some unwelcome news about the status of rehabbing lefty Drew Smyly. As Ryan Divish of the Seattle Times, plans for Smyly to face live hitting were scuttled after the southpaw experienced some elbow discomfort. Pitching coach Mel Stottlemyre explains that Smyly has dealt with other such “episodes” while working back from a flexor strain, especially when throwing breaking pitches, so perhaps this could just be a minor blip. Still, he’s slated for a medical examination; at present, there’s no clear indication of what’ll come next. “Until the doctors check, and all that stuff subsides, you just can’t move forward,” explains Stottlemyre. “It’s hard to make a plan going forward until we know more.”
Clearly, Seattle’s deadline plans could be altered by Smyly’s progress (or lack thereof). If the team finds itself in a strong Wild Card position at the end of July, but doesn’t think it’ll get the rotation boost it needs, it’s at least possible to imagine a move to bolster the rotation. Here are some more notable injury situations from around the game:
- Young Braves hurler Patrick Weigel is headed for Tommy John surgery, per David O’Brien of the Atlanta Journal-Constitution. That’s the result that was feared when it was learned that he had suffered a partial UCL tear. Soon to turn 23, Weigel had reached Triple-A in just his third professional season. He could’ve conceivably provided the Braves with a rotation option for 2018, so the loss should only increase the organization’s interest in adding a significant outside starter.
- It seems the Astros are wisely taking a measured approach with southpaw Dallas Keuchel, who is working back from a pinched nerve in his neck. As Jake Kaplan of the Houston Chronicle writes, skipper A.J. Hinch acknowledges that the club is “just being conservative” by “methodically putting a few more challenges in front of him” to bring Keuchel along slowly. With Keuchel in need of at some rehab outings before returning to the MLB hill, it seems he won’t likely make it back until after the All-Star break. That timeline surely works just fine for the front-running Astros, who are as close to a postseason shoe-in as there can be at this stage of the season.
- The Nationals’ bullpen needs have long been a focus of the 2017 trade season. Just how many arms the Nats will go looking for could well depend in part upon the progress of several current pitchers. Per a club update, via Mark Zuckerman of MASNsports.com (via Twitter), Sammy Solis appears to be making real strides after missing a significant stretch with elbow issues, as he was able to take the ball for Triple-A Syracuse. If the power lefty can return to health and to form, that’d be a significant boost. Meanwhile, Shawn Kelley (out with a trap strain) has resumed throwing — which is not yet the case for fellow righty Koda Glover (who is dealing with back issues).
- There’s some positive momentum for Indians righty Danny Salazar, as Jimmy Miller of the Akron Beacon Journal writes. Salazar says his shoulder feels good, and he’s now slated to begin a rehab assignment. The high-octane hurler, 27, could potentially re-take a spot in the rotation or provide Cleveland with another fascinating, multi-inning-capable bullpen arm.
- Likewise, the Cubs saw progress from righty Kyle Hendricks, as Patrick Mooney of CSN Chicago tweets that he was able to throw (albeit only from 90 feet) without experiencing any issues in his hand. Hendricks has been dealing with tendon problems in his pitching hand, leading to a DL placement. Before going down with the injury, Hendricks had turned in eleven somewhat worrying starts. Expectations were high after he landed third in the 2016 Cy Young voting, but Hendricks has shown a significant velocity loss (over two miles per hour on his fastball) and a big drop in swinging-strike rate (from 10.0% to 7.3%). Getting him healthy and back to form would represent a big boost to the Cubs, though it’s not clear whether they’ll have a real read on his capacity before making deadline plans.
- While the Reds haven’t yet made a move, it seems likely that lefty Brandon Finnegan is heading back to the DL. Initial indications were that he had only experienced a triceps strain during his first start after rehabbing an injury to the teres major muscle in his shoulder. Instead, per manager Bryan Price (on MLB Network Radio on Sirius XM, via Twitter), the injury was traced to that same muscle. While it’s said to be in a different part of the muscle, it nevertheless seems rather concerning that Finnegan is experiencing issues in that same narrow area. The broader prognosis remains unclear at this moment, though Price said he expects the southpaw to miss “at least … several weeks, if not longer.”
Drew Smyly Targeting Mid-July Return
- The Mariners have battled through a spate of injuries to post a 39-38 record and plant themselves firmly in the playoff hunt, and now a significant reinforcement is on the way. Left-hander Drew Smyly, out all season with an elbow injury, is targeting a return for the Mariners’ July 17-19 series against AL West rival Houston, relays Bob Dutton of the Tacoma News Tribune. Smyly threw a two-inning sim game Saturday, and the plan is for him to do the same on June 28 and then embark on a three-start rehab assignment in early July. The 28-year-old hasn’t yet pitched for the Mariners, who acquired him in an offseason trade with Tampa Bay.
Mariners Outright Tyler Cloyd
- Right-hander Tyler Cloyd has been outrighted to Triple-A by the Mariners after clearing waivers, per a club announcement. The former Phillies farmhand made his return to the Majors for the first time since 2013 this season, though he made just one appearance with Seattle before being designated for assignment. Cloyd, 30, spent the 2015 season in Korea and has pitched well in Triple-A and indy ball since returning stateside. Through 19 1/3 innings with Seattle’s Triple-A affiliate this year, he allowed just three earned runs on 12 hits and two walks with 16 strikeouts.
